Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin-induced Thrombocytopenia Type II”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Post-approval studies (Phase 4)Study completedNCT00039858
What this trial is testing

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Who this might be right for
ThrombocytopeniaThrombosis
Encysive Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT00861692
What this trial is testing

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Who this might be right for
Heparin-induced Thrombocytopenia Type II
Tanabe Pharma Corporation 20
Post-approval studies (Phase 4)WithdrawnNCT00759083
What this trial is testing

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Who this might be right for
Heparin-Induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis Syndrome
The Medicines Company
Large-scale testing (Phase 3)Study completedNCT00079508
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

Who this might be right for
Cardiovascular DiseaseCoronary Artery Bypass Surgery
The Medicines Company 125
Not applicableStudy completedNCT01304238
What this trial is testing

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

Who this might be right for
Acute HIT II (Heparin-induced Thrombocytopenia Type II)
GlaxoSmithKline 195
Testing effectiveness (Phase 2)Temporarily pausedNCT02501434
What this trial is testing

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin

Who this might be right for
Aneurysmal Subarachnoid HemorrhageNeurobehavioral ManifestationsVasospasm, Intracranial+2 more
Robert F. James 88
Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5
Large-scale testing (Phase 3)Study completedNCT00073580
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Who this might be right for
ThrombocytopeniaThrombosisCardiac Disease+1 more
The Medicines Company 88